VRVladimir Semenovich Ruzavin

Vladimir Semenovich Ruzavin

*This is an algorithmically generated author record based on publicly available information.

Vladimir Semenovich Ruzavin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-term postoperative outcomes in patients with hilar cholangiocarcinoma: a single-center experience

    by Yu.A. Kovalenko, A.D. Makarchev, O.YA. Muhtarov, T.V. Shevchenko, V.S. Ruzavin, B.N. Gurmikov

    Objective. To evaluate long-term postoperative outcomes in patients with hilar cholangiocarcinoma. Material and methods. This study included patients with hilar cholangiocarcinoma who underwent primary surgery at the Vishnevsky National Research Center of Surgery. Exclusion criteria: surgery outside our hospital, death within 90 days after surgery, distant metastases and combined hepatocellular carcinoma. Extent of surgery was determined by modern guidelines. Comparison groups included patients with different resection statuses. Statistical analysis was performed using STATISTICA 13 software. Results. The study included 92 patients (60 men (65.2%) and 32 women (34.8%)). Age ranged was from 18 to 83 years. Patients underwent resection of the common bile duct (13 (14.1%) cases), hemihepatectomy with bile duct resection (55 (59.8%) cases); extended hemihepatectomy with bile duct resection (16 (17.4%) cases), resection of extrahepatic bile ducts combined with PDE (1 (1.1%) case). In 32 (38.5%) cases, regional lymph node involvement was noted. We assessed all loci of tumor invasion in longitudinal and radial resection margins, as well as excised regional lymph nodes. According to our classification, resection status was as follows depending on the number of R+ loci and lymph node assessment: R0 — 7 (8.75%), R+1 — 2 (2.5%), R+2 — 7 (8.75%), R+3 — 3 (3.75%), R+4 — 6 (7.5%), R+5 — 14 (17.5%), R+6 — 21 (25.25%), R+7 — 20 (25%), respectively. According to multivariate analysis, significant factors of unfavorable prognosis were TNM stage (p=0.006), tumor cells in lymph nodes (p=0.01), differentiation grade (p=0.02) and perineural invasion (p=0.03). Overall 1-, 3-, 5-, 7- and 10-year survival rates were 70%, 30%, 18%, 16%, and 16%, respectively. Survival significantly differed between R0 and R+1—7 resection groups (p=0.01). Conclusion. Resection of extrahepatic bile ducts is radical for Bismuth-Corlette types I-II. Extensive liver resections are indicated for types III-IV. To assess resection quality, it is important to consider “clearness” of true resection margin, taking into account all loci of invasion. According to this approach, 5-year survival rate after R0 or R+1—2 resection is 100%.

  • Open Access

    Solitary Fibrous Tumor of the Liver Disguised as Hepatocellular Cancer

    by Vladimir Semenovich Ruzavin, Cyrill Leonidovich Gorlenko, Vadim Sergeevich Shirokov, Dmitry Valerievich Kalinin, Anton Borisovich Goncharov, Yuri Alekseevich Kovalenko, Yulia Alexandrovna Stepanova, Beslan Nuralievich Gurmikov

    Solitary fibrous tumor (SFT) is a rare neoplasm of mesenchymal origin characterised by NAB2 and STAT6 genes fusion. SFT occurs in one of 300.000 patients who seek medical attention. Incidence rate of liver SFT is unavailable due to a minor number of existing observations. In most cases, diagnosis of SFT is incidental. Yet, in 5% of cases, it manifests as paraneoplastic syndromes. Differential diagnosis using CT and MRI is complicated due to unspecific pattern of the neoplasm. This paper presents a clinical case of a 58-year-old patient who applied for a consultation at A.V. Vishnevsky National Medical Research Center of Surgery. Due to non-specificity, the laboratory and instrumental examination findings did not allow making a correct diagnosis at the preoperative stage. Histological examination findings helped to finally diagnose solitary fibrous tumor. Based on the data obtained, we can draw a conclusion about the imperfection of existing diagnostic options and the need to identify specific criteria for solitary fibrous tumor diagnosis.

  • Successful surgical treatment of a patient with pancreatic cancer metastases in the liver after prior pancreatoduodenal resection

    by Yu.A. Kovalenko, I.A. Turchenko, V.S. Ruzavin, V.A. Saraeva, O.I. Zhavoronkova, A.A. Paychadze, B.N. Gurmikov

    This clinical observation presents a case of successful right hemihepatectomy for pancreatic cancer metastases after previous pancreatoduodenal resection. The peculiarity of this clinical case lies in the difficulties of differential diagnosis, ultimately leading to the successful application of surgical treatment for oligometastatic disease. The aim of the study is to analyze diagnostic methods and determine factors influencing the choice of operative procedure for metachronous pancreatic cancer metastases.